| Criteria | Criteria description | Description of complete reporting for criteria |
---|---|---|---|
Methods | 1 | List addressed adverse events with definitions | Listed AEs with definitions (with attention to the grading, when relevant) |
2 | Mode for collecting data | Full description of questionnaires, interviews, or tests used to collect information on the harms. Detailed information on the questions asked | |
3 | Timing and time frame of surveillance | Description of the time frame of surveillance for AEs, with the stopping period detailed | |
4 | Attribution methods | Person responsible for making attribution disclosed and whether blinding was used | |
5 | Intensity of ascertainment | Specify clearly how the withdrawals are handled in the analyses | |
6 | Harms-related monitoring | Plans for monitoring and rules for stopping for the benefits and harms separately | |
7 | Coding of AEs | Reference to any coding system used and person responsible for the coding | |
8 | Handling of recurrent events | Specify how recurrent events are handled: detailed as separate events or as one | |
9 | Timing issues | Timing of events explained, if recurrent | |
10 | Plans to perform any statistical analyses and inferences | Described how pre-specified statistical analyses are separated from post hoc analyses, and any common problems addresses | |
Results | 11 | Withdrawals and discontinuations | Reasons for discontinuations and separated by arm. Flow diagrams used to display withdrawals |
12 | Denominators for analyses on harms | Analyses and definitions used and clearly stated (i.e. intention to treat (ITT)), and all denominators for safety population are clearly detailed | |
13 | Specifying AE type | Results presented separately by System Organ Classification type | |
14 | Grading or scaling used | Each AE type should offer appropriate metrics of absolute risk | |
15 | Seriousness per arm | Reported separately for each type of event |